Resources

Top-level science through the eyes of an expert.The first Webinar. This webinar episode is open to English-speaking participants with a solid scientific background. Featured speaker is globally renowned immunology expert Dr. Nicolas Gaudenzio. watch the replay Mast cells are tissue-resident immune cells best known for their detrimental role in allergic disorders via their expression of the high affinity IgE receptorRead more

Article by Pascal Descargues, first published in Life Science Leader on February 1, 2022. The original article is available here. What I Learned In A French Lab That Led To My Role As CEO The Path to the Aha Moment In 2006, I had just finished my Ph.D. in human pathophysiology, and I was working in a lab in Toulouse,Read more

Advancing New Approach Methodologies for ethical & reliable drug development New Approach Methodologies: Changing drug development as we know it Drug development is long, expensive, and painfully inefficient. With 90% of drug candidates failing before clinical approval, the industry is desperate for human-relevant, predictive tools—this is where New Approach Methodologies (NAMs) have emerged as a vital solution. At Genoskin, weRead more

PRESS RELEASE - Toulouse, France & Salem, MA, USA - December 6, 2021 GENOSKIN LAUNCHES SPATIAL SKIN BIOLOGY PLATFORM MANTIS® Genoskin launches MANTIS®, a spatial biology imaging platform dedicated to skin immunology. The MANTIS® (Multiplex ANnotated Tissue Imaging System) platform was developed at Infinity (Inserm U1291, France) by a team of experts under the guidance of Dr. Nicolas Gaudenzio, whoRead more

Genoskin appoints Dr Nicolas Gaudenzio as Chief Scientific Officer Today, November 8, Genoskin announces the appointment of Dr. Nicolas Gaudenzio as Chief Scientific Officer (CSO), starting in November. Dr. Gaudenzio will lead Genoskin's shift towards new activities Dr. Gaudenzio is a world-renowned researcher and expert in immunology and allergic skin inflammation. He is also principal investigator and leader of aRead more

Article written by Danny Sullivan and first published in Longevity Technology on October 28th, 2021. The original article is available here. Genoskin can help de-risk antiaging trials with the only live human skin model available for subcutaneous administration testing With its proprietary ex vivo human skin technologies, French partner research organisation Genoskin says it is paving the way to “better,Read more